Where might Colby Rasmus play next year?

11 Comments

If the rift between Tony La Russa and Colby Rasmus forces the Cardinals to part with their 24-year-old center fielder, there will surely a be a ton of interest. Rasmus is hitting .266/.352/.496 in his second big-league season, and he’s not close to reaching his ceiling. He’s also a Gold Glove-caliber defender. He should be a building block in St. Louis, but if the Cards decide to make a move, it’s not like they’ll have to settle for 10 cents on the dollar. Let’s look at some of the teams that could be interested:
Boston: The Red Sox are thinking of moving on from Jacoby Ellsbury anyway and there’s certainly no better long-term replacement available than Rasmus, though with Mike Cameron signed and Ryan Kalish showing some potential, the Red Sox wouldn’t necessarily need to bring in a center fielder to replace Ellsbury. Whether a Boston trade would work would likely come down to how the Cardinals feel about Ellsbury. They could certainly use the leadoff hitter, but Ellsbury’s stock has taken a hit as a result of his injury-ruined season. The Cardinals would probably want a top prospect to go along with him, perhaps right-hander Casey Kelly or shortstop Jose Iglesias. Ellsbury and Jed Lowrie for Rasmus could be more to Boston’s liking.
Tampa Bay: B.J. Upton has stepped it up offensively in recent weeks and hasn’t exhibited the signs of laziness that got him benched earlier this season, but if the Rays could use him and one of their young pitchers to upgrade to Rasmus, it’d be a brilliant move. Jeremy Hellickson would be off limits, but Wade Davis or Jeff Niemann could work. My guess is that the Cardinals would want top outfield prospect Desmond Jennings instead of Upton.
L.A. Dodgers: Matt Kemp for Rasmus? It’d seem to work great as a challenge trade. Kemp is one of the few players in the game with as much natural talent as Rasmus, and while he has taken a big step backwards this year, he was probably one of the NL’s top 10 players a year ago. He’s also just two years older than Rasmus. The big issue is that he’s also two years closer to free agency. Kemp will make $6.95 million next year and will be arbitration eligible in 2012 before becoming a free agent. That might be enough to scare the Cardinals off, unless maybe the Dodgers are willing to add in some young talent.
Atlanta: Just imagine Rasmus and Jason Heyward playing together for the next several years. Now move on, because it seems pretty unlikely to happen. The Braves have the pieces to tempt the Cardinals in left-hander Mike Minor, right-hander Julio Teheran and possible future closer Craig Kimbrel, but they’re going to need those guys soon with Derek Lowe looking like an iffy bet going forward and Billy Wagner set to retire.
San Diego: The Padres haven’t made big trades in recent years, but maybe they’ll be willing to roll the dice now that they seem so well set up for 2011. Rasmus would be a huge get as a long-term center fielder, and with Chase Headley and pitchers like Cory Luebke, Luke Gregerson, Wade LeBlanc and Tim Stauffer, they can part with pieces that could contribute in St. Louis immediately.
Washington: It’d be quite a coup if the Nationals could solve their center-field problems with Rasmus, but they don’t seem to match up very well with the Cardinals. They can afford to part with either Ian Desmond or Danny Espinosa, yet they need to hold on to most of their young pitching. Jordan Zimmermann and Drew Storen would be awfully attractive pieces if made available, but both should stay put. The Nationals can afford to be aggressive in free agency in an effort to beef up their offense.
L.A. Angels: Peter Bourjos is truly outstanding defensively and he’ll make the minimum these next three years, so the Angels might as well stick with him and look to upgrade elsewhere. Maybe they could build a trade package around Bourjos and their other young talent, but they just have too many weaknesses to tie up so many resources in a single upgrade at a position where they could be OK.
N.Y. Yankees: Simply because they can never be ruled out of these things. Still, if the Yankees go get themselves an outfielder this winter, I expect it will be Carl Crawford.
N.Y. Mets: The only way a deal would make much sense here is if the Cardinals fell in love with Angel Pagan and were willing to take him and some lesser talent for Rasmus. Upgrading in center won’t be a priority for the Mets this winter.

The Rangers trade Chris Gimenez to the Indians

Texas Rangers' Chris Gimenez, left, and Rougned Odor celebrate Gimenez scoring during the fourteenth inning of Game 2 in baseball's American League Division Series, Friday, Oct. 9, 2015, in Toronto. Texas won 6-4. (Darren Calabrese/The Canadian Press via AP) MANDATORY CREDIT
Associated Press
Leave a comment

The Cleveland Indians just announced that they’ve acquired catcher Chris Gimenez from the Texas Rangers in exchange for cash considerations.

Gimenez knows his way to Progressive Field. Indeed, this will be his third stint with the Indians organization. He was their 19th round pick in the 2004 draft, made his big league debut with the club in 2009 and stayed through the 2010 season. He came back in 2014 for eight games, now he’s back again. He has yet to play in 2016 due to a ankle issue. He as doing minor league rehab before being DFA’d by the Rangers yesterday.

Come back to Cleveland, Chris. You always will have a home in Cleveland.

The Dodgers suspend Erisbel Arruebarrena for the season. Again.

Erisbel Arruebarrena
Leave a comment

Last year the Dodgers suspended infielder Erisbel Arruebarrena for the remainder of the season“for repeated failures to comply with his contract.” Arreubarrena appealed his suspension to Major League Baseball and it was reduced to thirty days, though that was said to be a settlement between Arruebarrena and the Dodgers as opposed to a full adjudication.

Here we go again: Gabe Kapler, the Dodgers Director of Player Development, just announced that the Dodgers have suspended Arruebarrena for the rest of 2016 “for repeated failure to comply with the terms of his contract.” No further specifics were given.

Arruebarrena was signed out of Cuba to to a five-year, $25 million deal back in 2013. He played in 22 games in the bigs in 2014, hitting .195. He was dropped from the 40-man roster after that season, however, and after his suspension last year managed to only play in 53 games across three levels. He hit better, but none of his action was above Double-A and he was 25 at the time. He’s played 17 games at Double-A this year and isn’t hitting.

What he was or was not doing with respect to his contract is unclear at the moment, but this isn’t exactly the kind of thing that happens on a daily basis, especially with dudes under contract for $25 million, so we’ll probably hear more eventually.

Braves’ Markakis misses game because of family emergency

Nick Markakis, Nick Swisher
3 Comments

NEW YORK (AP) Braves right fielder Nick Markakis has left the team because of a family emergency.

Manager Fredi Gonzalez said before Wednesday’s game against the Mets that Markakis had headed home to Maryland. The veteran is expected to be back in time for Friday’s home game against Arizona. Atlanta is off Thursday.

Chase d’Arnaud is starting in right field and Mallex Smith is leading off Wednesday.

Markakis is hitting .281 with no home runs and 20 RBIs.

Report: more major league PED suspensions coming soon

FILE - In this May 30, 2007 file photo a blister with the steroid Oral-Turinabol is displayed in Dresden, eastern Germany. Oral-Turinabol was the main drug in the state-controlled doping in former East Germany.    (AP Photo/Matthias Rietschel, file)
Associated Press
20 Comments

T.J. Quinn of ESPN’s Outside the Lines reports that another major leaguer — or possibly several of them — will soon be suspended for PEDs. He says that, as was the case with Chris Colabello and others recently, the drug will be Turinabol, which is an old school anabolic steroid. Quinn says that improved testing procedures, which he details in the article, are a likely reason for the spike in Turinabol positives, though it’s also possible that there is a tainted supplement being taken, though he deems that speculative.

What isn’t mentioned is . . . how an ESPN reporter knows a positive test is coming when the drug testing program is supposed to be confidential. Someone with the league or the union must be telling him, right? That’s sort of messed up, no? Will MLB investigate who is leaking such things?

Whatever the case, we’ll soon have a new police blotter item, it seems.